John L. Barlament’s articles from Reinhart Boerner Van Deuren s.c. are most popular:
- within Employment and HR topic(s)
Reinhart Boerner Van Deuren s.c. are most popular:
- within Litigation, Mediation & Arbitration and Criminal Law topic(s)
- with readers working within the Accounting & Consultancy and Retail & Leisure industries
Reinhart shareholders John Barlament and Katie Kratcha recently hosted a webinar in which they reviewed a number of legal and regulatory developments impacting plan sponsors, prescription drug plans and health plan vendors. Of these developments, there are four that plan sponsors and health plan vendors should monitor. Some of the effective dates and impacts are immediate, while others will play out over the next few years.
Click the video above to view the webinar, and click here if you would like to review the slides covered in the session.
Topics Discussed
- TrumpRx website
- Federal Trade Commission (FTC) settlement with Express Scripts, Inc.
- Consolidated Appropriations Act (CAA) 2026 Changes
- Proposed pharmacy benefit manager (PBM) compensation disclosure regulations
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
[View Source]
